|
ARL13B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.81759999998243E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10250000000078E-05 |
| Normal-vs-Stage2 |
6.199500E-04 |
| Normal-vs-Stage3 |
1.402250E-04 |
| Normal-vs-Stage4 |
2.01890000000038E-05 |
| Stage1-vs-Stage2 |
5.308400E-01 |
| Stage1-vs-Stage3 |
6.299400E-01 |
| Stage1-vs-Stage4 |
8.089600E-01 |
| Stage2-vs-Stage3 |
9.002400E-01 |
| Stage2-vs-Stage4 |
7.017000E-01 |
| Stage3-vs-Stage4 |
7.867000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.77000000001604E-07 |
| Normal-vs-AfricanAmerican |
1.65490000003654E-06 |
| Normal-vs-Asian |
7.591000E-01 |
| Caucasian-vs-AfricanAmerican |
1.965840E-01 |
| Caucasian-vs-Asian |
2.309600E-01 |
| AfricanAmerican-vs-Asian |
6.448000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.04640000395418E-08 |
| Normal-vs-Female |
4.205000E-04 |
| Male-vs-Female |
3.288000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.034100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.20719999999286E-05 |
| Normal-vs-Age(61-80Yrs) |
1.46430000003139E-06 |
| Normal-vs-Age(81-100Yrs) |
1.59842999999382E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.681400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.128200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.187800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.211400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.601700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.712010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.091800E-01 |
| Normal-vs-Grade 2 |
9.823500E-04 |
| Normal-vs-Grade 3 |
6.33419983131489E-11 |
| Normal-vs-Grade 4 |
6.41239999987775E-07 |
| Grade 1-vs-Grade 2 |
3.939200E-01 |
| Grade 1-vs-Grade 3 |
6.855300E-03 |
| Grade 1-vs-Grade 4 |
2.640200E-02 |
| Grade 2-vs-Grade 3 |
1.117990E-02 |
| Grade 2-vs-Grade 4 |
7.353600E-02 |
| Grade 3-vs-Grade 4 |
7.291200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.498100E-03 |
| Normal-vs-ccB subtype |
1.18270000004639E-06 |
| ccA subtype-vs-ccB subtype |
1.472330E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.84369999995027E-06 |
| Normal-vs-N1 |
5.804200E-02 |
| N0-vs-N1 |
7.022600E-01 |
|
|
